Trials
Search / Trial NCT06418230

EXOME SEQUENCING IN MEDULLARY SPONGE KIDNEY

Launched by HOSPICES CIVILS DE LYON · May 13, 2024

Apply for Trial

Trial Information

Current as of March 13, 2025

Active, not recruiting

Keywords

Exome Nephrolithiasis Medullary Sponge Kidney

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • medullary sponge kidney attending medical consultation
  • • consent signed
  • • affiliated to social insurance scheme
  • Exclusion Criteria:
  • • legal protection measure (guardianship, curatorship)
  • • Deprived of liberty by a judicial or administrative decision
  • • subject participating in another research including an exclusion period still in progress at inclusion

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Lyon, , France

Marseille, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0